PO14 | Searching for safer rescue immunosuppressive therapy protocols in acquired hemophilia A: two case reports
Background: Eradication of autoantibodies (inhibitors) against Factor VIII (FVIII) by immunosuppressive therapy (IST) is a cornerstone of treatment of acquired hemophilia A (AHA). First-line IST usually relies on corticosteroids, while cyclophosphamide or rituximab are used/combined as rescue treat...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
PAGEPress Publications
2025-08-01
|
| Series: | Bleeding, Thrombosis and Vascular Biology |
| Subjects: | |
| Online Access: | https://www.btvb.org/btvb/article/view/275 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PO65 | Utilization of emicizumab in acquired hemophilia A: a case report
Published: (2025-08-01) -
PO90 | Acquired hemophilia A with high-titer inhibitor in a patient with cardiovascular and metabolic comorbidities
Published: (2025-08-01) -
PO47 | Hemophilia A and antithrombin deficiency: a case of natural hemostatic rebalancing
Published: (2025-08-01) -
PO44 | Emicizumab in acquired haemophilia A
Published: (2025-08-01) -
PO55 | Evaluation of safety and efficacy of emicizumab prophylaxis in pediatric patients with hemophilia A – a single centre experience
Published: (2025-08-01)